AVPCancerFree : Impact of a digital behavior change intervention on parental HPV vaccine -related perceptions and behaviors.

Autor: Shegog R; Department of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA., Savas LS; Department of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA., Healy CM; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA., Frost EL; Department of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA., Coan SP; Department of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA., Gabay EK; Department of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA., Preston SM; Department of Behavioral Sciences, UTHealth School of Public Health, Dallas, TX, USA., Spinner SW; Department of Pediatrics, Texas Children's Pediatrics, Houston, TX, USA., Wilbur M; Department of Pediatrics, Texas Children's Pediatrics, Houston, TX, USA., Becker E; Department of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA., Teague T; Department of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA., Vernon SW; Department of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA.
Jazyk: angličtina
Zdroj: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Nov 30; Vol. 18 (5), pp. 2087430. Date of Electronic Publication: 2022 Jun 14.
DOI: 10.1080/21645515.2022.2087430
Abstrakt: Parent hesitancy contributes to reduced HPV vaccination rates. The HPVcancerfree app (HPVCF) was designed to assist parents in making evidence-based decisions regarding HPV vaccination. This study examined if parents of vaccine-eligible youth (11-12 yrs.) who use HPVCF in addition to usual care demonstrate significantly more positive intentions and attitudes toward HPV vaccination and greater HPV vaccination rates compared to those not using HPVCF. Clinics (n = 51) within a large urban pediatric network were randomly assigned to treatment (HPVCF + usual care) or comparison (usual care only) conditions in a RCT conducted between September 2017 and February 2019. Parents completed baseline and 5-month follow-up surveys. Participant-level analysis determined 1) change in HPV vaccination initiation behavior and related psychosocial determinants and 2) predictors of HPV vaccine initiation. Parents (n = 375) who completed baseline and 5-month follow-up surveys were female (95.2%), 40.8 (±5.8) yrs. married (83.7%), employed (68.3%), college educated (61.9%), and privately insured (76.5%). Between-group analysis of HPVCF efficacy demonstrated that parents assigned to receive HPVCF significantly increased knowledge about HPV and HPV vaccination ( p  < .05). Parents who accessed content within HPVCF significantly increased knowledge about HPV & HPV vaccine ( p  < .01) and perceived effectiveness of HPV vaccine ( p  < .05). Change in HPV vaccine initiation was not significant. A multivariate model to describe predictors of HPV vaccine initiation demonstrated an association with Tdap and MCV vaccination adoption, positive change in perceived effectiveness of the HPV vaccine, and reduction in perceived barriers against HPV vaccination. HPVCF appears to be a feasible adjunct to the education received in usual care visits and reinforces the value of apps to support the important persuasive voice of the health-care provider in overcoming parent HPV vaccine hesitancy.
Databáze: MEDLINE